Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹997 Cr.
Stock P/E
21.9
P/B
7.2
Current Price
₹581.2
Book Value
₹ 80.2
Face Value
10
52W High
₹820
52W Low
₹ 153.6
Dividend Yield
0%

Unihealth Hospitals Overview

Business

Unihealth Hospitals Ltd. operates within the Hospital & Healthcare Services sector in India. The company's core business involves establishing and managing multi-specialty hospitals and healthcare facilities. It provides a comprehensive range of medical services including inpatient and outpatient care, diagnostic services, surgical procedures, emergency services, and pharmacy operations. The business model is centered on delivering accessible and quality healthcare, generating revenue primarily through patient fees for consultations, treatments, surgeries, bed charges, and sales of pharmaceutical products.

Revenue Mix

While specific revenue contributions are not publicly available without detailed financial reports, the typical revenue streams for a hospital chain like Unihealth include:

Inpatient Services: Revenue from patient admissions, surgeries, procedures, and room charges.

Outpatient Services: Income from consultations, day care procedures, and minor treatments.

Diagnostics: Revenue from pathology, radiology, and other diagnostic tests.

Pharmacy: Sales of medicines and medical consumables.

Other Services: Potentially includes health check-ups, preventive care programs, and medical tourism.

Industry

The Indian Hospital & Healthcare Services industry is characterized by significant growth, driven by increasing demand for quality healthcare. It is a diverse market with large corporate hospital chains, regional players, single-specialty hospitals, and numerous small clinics. The industry is still largely fragmented but is witnessing increasing consolidation and corporatization. Unihealth Hospitals operates within this competitive landscape, likely positioning itself as a regional or emerging multi-city player, focusing on delivering standardized care. Its positioning relative to market leaders would depend on its geographical footprint, bed capacity, specialty focus, and brand reputation.

MOAT

For a hospital company, potential competitive advantages include:

Brand Reputation & Trust: A strong reputation for clinical excellence, patient outcomes, and ethical practices.

Physician Network: The ability to attract and retain highly skilled doctors and medical professionals.

Specialized Expertise: Offering niche or advanced medical procedures that are difficult to replicate.

Location & Accessibility: Strategically located facilities offering convenience to patients.

Scale & Efficiency: Larger chains can achieve cost efficiencies in procurement, technology, and administration.

The extent to which Unihealth possesses these advantages would depend on its operational track record, investment in talent and technology, and its market presence. A durable moat typically takes time to build in the healthcare sector.

Growth Drivers

Key factors that can drive growth for Unihealth Hospitals over the next 3-5 years include:

Rising Healthcare Expenditure: Increasing disposable incomes and greater awareness leading to higher spending on health.

Growing Health Insurance Penetration: Expansion of government schemes (e.g., Ayushman Bharat) and private insurance increasing affordability.

Demographic Shifts: An aging population and rising incidence of chronic diseases requiring specialized care.

Demand for Quality Healthcare: A persistent gap in quality healthcare infrastructure, particularly in tier-2 and tier-3 cities.

Medical Tourism: India's potential as a destination for affordable high-quality medical treatment.

Expansion & Capacity Addition: Organic growth through new facility launches or inorganic growth through acquisitions.

Risks

Intense Competition: Highly competitive market with established players and new entrants.

Regulatory & Policy Changes: Government interventions like price caps on medical procedures, drug price controls, and changes in healthcare policies.

High Capital Expenditure: Significant ongoing investment required for infrastructure, medical equipment, and technology.

Talent Acquisition & Retention: Shortage and high cost of qualified doctors, nurses, and allied healthcare professionals.

Medical Malpractice & Litigation: Risk of legal challenges related to patient care.

Operational Efficiency: Challenges in maintaining high utilization rates and managing costs effectively across multiple facilities.

Ethical & Reputational Risks: Maintaining trust and avoiding controversies related to pricing or treatment.

Management & Ownership

As an Indian listed company, Unihealth Hospitals Ltd. is likely promoted by a founding family or a group of entrepreneurs. The quality of management in the healthcare sector is critical, encompassing not only business acumen but also clinical excellence, ethical governance, and patient safety standards. The ownership structure would typically involve a significant promoter holding, alongside institutional investors (if any) and public shareholders. The ability of the management to execute expansion plans, attract top medical talent, and maintain operational efficiency will be crucial for the company's success.

Outlook

Unihealth Hospitals Ltd. operates in a sector poised for robust growth in India, driven by fundamental demographic and economic tailwinds. The increasing demand for accessible and quality healthcare presents a significant opportunity for expansion and value creation. However, the company faces substantial challenges, including intense competition from well-established national and regional chains, high capital expenditure requirements for expansion and technology upgrades, and the inherent risks associated with healthcare regulations and talent management. Success will largely depend on the management's ability to execute a disciplined growth strategy, build a strong brand reputation based on clinical outcomes and patient trust, and achieve operational efficiencies in a capital-intensive and highly regulated environment.

Unihealth Hospitals Share Price

Live · NSE · Inception: 2010
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Unihealth Hospitals Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Unihealth Hospitals Profit & Loss

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 22 26 37 44 49 99 132
Other Income 1 2 1 2 2 3 5
Total Income 23 29 38 46 50 102 137
Total Expenditure 20 20 25 30 31 62 78
Operating Profit 3 9 13 16 19 39 59
Interest 2 1 5 4 3 3 2
Depreciation 2 2 2 3 2 6 10
Exceptional Income / Expenses 0 0 0 0 0 0 0
Profit Before Tax -1 5 5 9 14 30 46
Provision for Tax 0 1 1 2 3 3 1
Profit After Tax -1 5 4 8 10 27 45
Adjustments 0 0 0 0 -0 -13 -20
Profit After Adjustments -1 5 4 8 10 14 26
Adjusted Earnings Per Share -0.8 4.7 3.6 6.9 6.7 9.2 16.5

Unihealth Hospitals Balance Sheet

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 6 11 15 28 85 101 138
Minority's Interest -0 -0 -0 -0 -0 40 60
Borrowings 35 37 36 36 12 5 16
Other Non-Current Liabilities 0 1 1 1 2 9 11
Total Current Liabilities 18 10 13 14 11 29 29
Total Liabilities 58 58 65 78 110 185 254
Fixed Assets 35 35 36 37 36 68 84
Other Non-Current Assets 3 1 5 8 8 8 14
Total Current Assets 20 22 24 33 67 109 156
Total Assets 58 58 65 78 110 185 254

Unihealth Hospitals Cash Flow

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 1 1 2 2 2 13 8
Cash Flow from Operating Activities 1 4 9 1 5 3 6
Cash Flow from Investing Activities -2 -0 -2 -5 -2 -5 -24
Cash Flow from Financing Activities 1 -3 -5 3 21 -3 16
Net Cash Inflow / Outflow -0 0 2 -0 24 -5 -2
Closing Cash & Cash Equivalent 1 2 2 2 29 8 10

Unihealth Hospitals Ratios

# Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) -0.79 4.67 3.56 6.91 6.69 9.17 16.45
CEPS(Rs) 1.18 6.65 5.59 9.15 8.21 21.48 35.43
DPS(Rs) 0 0 0 0 0 0 0
Book NAV/Share(Rs) 5.29 9.97 13.78 24.76 55.49 65.82 86.69
Core EBITDA Margin(%) 9.64 24.87 31.24 31.04 36.26 37.13 40.76
EBIT Margin(%) 3.76 25.8 28.21 30.09 34.9 33.86 36.85
Pre Tax Margin(%) -4.1 20.89 14.13 21.12 27.98 30.68 35.07
PAT Margin (%) -4.17 18.89 10.3 17.43 21.3 27.38 34.43
Cash Profit Margin (%) 5.7 27.22 16.3 23.16 25.95 33.39 42.15
ROA(%) -1.59 8.48 6.16 10.7 11.02 18.35 20.68
ROE(%) -16.31 60.42 29.75 36.19 18.39 29.04 38.28
ROCE(%) 1.8 14.12 20.33 22.11 20.33 30.73 35.16
Receivable days 206.09 186.19 160.43 189.39 228.21 213.18 284.19
Inventory Days 12.25 15.37 16.15 16.24 15.71 11.64 15.32
Payable days 382.2 212.59 73.23 110.45 114.45 73.32 107.92
PER(x) 0 0 0 0 20.17 15.26 22.03
Price/Book(x) 0 0 0 0 2.43 2.13 4.18
Dividend Yield(%) 0 0 0 0 0 0 0
EV/Net Sales(x) 1.84 1.45 1 0.88 3.99 2.18 4.39
EV/Core EBITDA(x) 13.48 4.25 2.94 2.46 10.09 5.48 9.86
Net Sales Growth(%) 0 17.89 40.54 19.27 10.98 103.22 33.23
EBIT Growth(%) 0 710.09 53.62 27.25 28.72 97.14 44.98
PAT Growth(%) 0 634.01 -23.39 101.89 35.64 161.18 67.55
EPS Growth(%) 0 691.86 -23.73 94.15 -3.13 37.05 79.37
Debt/Equity(x) 7.16 3.62 2.57 1.43 0.18 0.16 0.16
Current Ratio(x) 1.15 2.15 1.85 2.32 5.87 3.78 5.33
Quick Ratio(x) 1.11 2.01 1.71 2.17 5.68 3.64 5.1
Interest Cover(x) 0.48 5.25 2 3.35 5.04 10.65 20.79
Total Debt/Mcap(x) 0 0 0 0 0.07 0.08 0.04

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +33% +44% +38% —
Operating Profit CAGR +51% +54% +46% —
PAT CAGR +67% +78% +55% —
Share Price CAGR +261% +64% — —
ROE Average +38% +29% +30% +28%
ROCE Average +35% +29% +26% +21%

Unihealth Hospitals Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 69.53 %
FII 0 %
DII (MF + Insurance) 0.48 %
Public (retail) 29.99 %
# Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026
Promoter 68.868.868.9368.9369.1469.53
FII 5.6100000
DII 0.350.140.020.230.750.48
Public 25.2331.0531.0530.8330.1129.99
Others 000000
Total 100100100100100100

Unihealth Hospitals Peer Comparison

Hospital & Healthcare Services Edit Columns

Unihealth Hospitals Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Unihealth Hospitals Pros & Cons

Pros

  • Company has delivered good profit growth of 55% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 29%
  • Company is almost debt free.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend.
  • Debtor days have increased from 73.32 to 107.92days.
  • Stock is trading at 7.2 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp